Cleared Traditional

K810213 - DAC-CEL TSH

K810213 is the FDA 510(k) clearance for DAC-CEL TSH by Burroughs Wellcome Co.. It is a Class 2 Chemistry device (product code JLW) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K810213 · Burroughs Wellcome Co. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1981
Decision
14d
Days
Class 2
Risk

K810213 is an FDA 510(k) clearance for the DAC-CEL TSH. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Burroughs Wellcome Co. (Walker, US). The FDA issued a Cleared decision on February 10, 1981 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Burroughs Wellcome Co. devices

Submission Details

510(k) Number K810213 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 1981
Decision Date February 10, 1981
Days to Decision 14 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 88d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 157
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K810213.
RADIOIMMUNOASSAY FOR HUMAN THYROID
K813392 · Leeco Diagnostics, Inc. · Dec 1981
AMERLEX TSH RIA KIT
K812136 · Amersham Corp. · Aug 1981
TECHNICON STAR SYSTEM
K811431 · Technicon Instruments Corp. · Jun 1981
TSH RADIOIMMUNOASSAY KIT
K802467 · American Diagnostic Corp. · Oct 1980
VENTREX/SEP TSH TEST SET
K801560 · Ventrex Laboratories, Inc. · Aug 1980
HUMAN THYROID STIM. HORMONE/ARIA II
K800798 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1980